2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base …
S Dorbala, Y Ando, S Bokhari… - Circulation …, 2021 - Am Heart Assoc
Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …
[HTML][HTML] Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for …
Parametric mapping techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …
Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel
After a reperfused myocardial infarction (MI), dynamic tissue changes occur (edema,
inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and …
inflammation, microvascular obstruction, hemorrhage, cardiomyocyte necrosis, and …
T1 mapping: basic techniques and clinical applications
In cardiac magnetic resonance (CMR) imaging, the T1 relaxation time for the 1H
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …
magnetization in myocardial tissue may represent a valuable biomarker for a variety of …
Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
S Neubauer, P Kolm, CY Ho, RY Kwong… - Journal of the American …, 2019 - jacc.org
Abstract Background: The HCMR (Hypertrophic Cardiomyopathy Registry) is a National
Heart, Lung, and Blood Institute–funded, prospective registry of 2,755 patients with …
Heart, Lung, and Blood Institute–funded, prospective registry of 2,755 patients with …
Myocardial fibrosis and cardiac decompensation in aortic stenosis
CWL Chin, RJ Everett, J Kwiecinski, AT Vesey… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: Cardiac magnetic resonance (CMR) was used to investigate the extracellular
compartment and myocardial fibrosis in patients with aortic stenosis, as well as their …
compartment and myocardial fibrosis in patients with aortic stenosis, as well as their …
[HTML][HTML] T1-mapping in the heart: accuracy and precision
The longitudinal relaxation time constant (T1) of the myocardium is altered in various
disease states due to increased water content or other changes to the local molecular …
disease states due to increased water content or other changes to the local molecular …
Distribution and prognostic significance of left ventricular global longitudinal strain in asymptomatic significant aortic stenosis: an individual participant data meta …
J Magne, B Cosyns, BA Popescu… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: In this individual participant data meta-analysis on left ventricular global
longitudinal strain (LVGLS), our objective was to: 1) describe its distribution; 2) identify the …
longitudinal strain (LVGLS), our objective was to: 1) describe its distribution; 2) identify the …
Extracellular myocardial volume in patients with aortic stenosis
Background Myocardial fibrosis is a key mechanism of left ventricular decompensation in
aortic stenosis and can be quantified using cardiovascular magnetic resonance (CMR) …
aortic stenosis and can be quantified using cardiovascular magnetic resonance (CMR) …